Discover trends, market shifts, and competitive outlooks for the pulmonary embolism industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Pulmonary Embolism Market In 2029?

The market for pulmonary embolism has seen swift growth in the past few years. It is predicted to rise from $2.03 billion in 2024 to $2.27 billion in 2025, with a compound annual growth rate (CAGR) of 11.9%. This growth during the historic period is credited to advances in anticoagulant therapies, extensive research and clinical trials, increased awareness of pulmonary embolism, and the use of vte prophylaxis.

In the coming years, the market size of pulmonary embolism is predicted to experience swift expansion. By 2029, it is projected to reach $3.63 billion with a 12.5% compound annual growth rate (CAGR). This anticipated rise during the forecast duration can be credited to factors such as targeted treatments, telemedicine and remote surveillance, health equality drives, and worldwide health campaigns. The prediction period will witness key trends including the integration of artificial intelligence in diagnosis, the use of new anticoagulants, pulmonary embolism response squads, and a greater focus on patient-driven care.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

Which Factors and External Forces Are Driving Demand in the Pulmonary Embolism Market?

The growth of the pulmonary embolism market is anticipated to be fueled by the escalating occurrence of blood clots. Blood clots, or thrombi, are semi-solid or gel-like formations in a blood vessel. They amplify the pulmonary embolism risk by hindering blood supply to the lungs. Often formed chiefly in the deep veins of the legs, blood clots heighten the likelihood of pulmonary embolism. As indicated in an April 2022 article by Gavi, the Vaccine Alliance – an international entity aimed at enhancing the accessibility of new and underutilized vaccines for kids – in the 30 days post-COVID-19 exposure, researchers found a 33-fold surge in the possibility of lethal lung clots and a five-fold uptick in the risk of deep vein thrombosis. Thus, the mounting incidence of blood clots is pushing the pulmonary embolism market’s growth. Driving the pulmonary embolism market is the growing prevalence of cancer. The term ‘cancer’ denotes diseases marked by abnormal, unregulated cell growth in the body. The rise in cancer cases boosts the chances of blood clots, like pulmonary embolism, especially among patients. This, in turn, drives demand for diagnostic procedures and treatments, including specialized drugs. For example, the American Cancer Society, a US-based nonprofit advocating for cancer, reported in January 2024 that cancer instances rose to 2,001,140 from 1,958,310 in 2023, indicating a 2.19% growth rate. Therefore, as cancer prevalence increases, it continues to fuel the expansion of the pulmonary embolism market.

Which Segments in the Pulmonary Embolism Offer the Most Growth?

The pulmonary embolism market covered in this report is segmented –

1) By Treatment: Medications, Mechanical Devices, Other Treatments

2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis

3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Medications: Anticoagulants, Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy, Supportive Care

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp

What Are the Fastest-Growing Geographies in the Pulmonary Embolism Market?

North America was the largest region in the pulmonary embolism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary embolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive thePulmonary Embolism Market’s Growth?

In the pulmonary embolism market, top-tier companies are concentrating their efforts on creating innovative products such as the Triever16 Curve catheter and the RevCore thrombectomy catheter to stay competitive. For instance, the US-based medical device company, Inari Medical Inc., introduced the Triever16 Curve catheter and the RevCore thrombectomy catheter to the market in June 2023. The recently introduced Triever16 Curve catheter is specifically tailored for peripheral thrombectomy and pulmonary embolism processes. The key features of this catheter include excellent trackability and a pre-moulded curve for focused aspiration. Its unique design allows for easy access to larger and more robust 20F or 24F catheters. The RevCore thrombectomy catheter, on the other hand, targets the treatment of venous in-stent thrombosis. This mechanical thrombectomy device employs a nitinol basket to trap and remove blood clots. Furthermore, these catheters enhance the safety and efficacy of pulmonary embolism procedures.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

What Are the Key Elements That Define the Pulmonary Embolism Market?

A pulmonary embolism is a blockage in the pulmonary artery, which transports blood from the heart to the lungs. It causes the clot of blood that has gone to the lungs from another area of the body, most commonly the legs, which causes blockage. The symptoms of pulmonary embolism might range from abrupt shortness of breath to chest pain, coughing up blood or bloody mucus and others, depending on the severity of the clot.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13026

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model